[Federal Register Volume 68, Number 142 (Thursday, July 24, 2003)]
[Notices]
[Page 43732]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-18875]



[[Page 43732]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, National Cooperative Drug Discovery 
Groups for Tuberculosis and Biodefense and Emerging Infectious 
Diseases Research.
    Date: August 13-14, 2003.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Chevy Chase, Terrace Room, 5520 Wisconsin 
Avenue, Chevy Chase, MD 20815.
    Contact Person: Gerald L. McLaughlin, PhD., Scientific Review 
Administrator, Scientific Review Program, National Institute of 
Allergy and Infectious Diseases, DEA/NIH/DHHS, 6700-B Rockledge 
Drive, MSC 7616, Room 2212, Bethesda, MD 20892-7616, 301-436-7465, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS).

    Dated: July 18, 2003.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 03-18875 Filed 7-23-03; 8:45 am]
BILLING CODE 4140-01-M